BIO-TECHNE Corp (TECH) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-02-17 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: BIO-TECHNE Corp (TECH) CIK: 0000842023 --- Reporting Owner --- Name: Herr Amy E. CIK: 0002055523 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-02-17 | Code: S (Open market sale) Shares: -1,976 | Price: $59.10 Total Value: $116,791.48 Shares Owned After: 200 | Ownership: I (Indirect) | Nature: By significant other Footnotes: [F1] The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.091 to $59.1390, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. --- Holdings --- [Holding #1] Security: Common Stock Ownership: D (Direct) [Holding #2] Security: Stock Option (Right to Buy) Ownership: D (Direct) [Holding #3] Security: Stock Option (Right to Buy) Ownership: D (Direct) Footnotes: [F2] This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders. [Holding #4] Security: Stock Option (Right to Buy) Ownership: I (Indirect) Footnotes: [F3] Fully vested. [Holding #5] Security: Stock Option (Right to Buy) Ownership: I (Indirect) Footnotes: [F3] Fully vested. [Holding #6] Security: Stock Option (Right to Buy) Ownership: I (Indirect) Footnotes: [F3] Fully vested. [Holding #7] Security: Stock Option (Right to Buy) Ownership: I (Indirect) Footnotes: [F4] Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026. [Holding #8] Security: Stock Option (Right to Buy) Ownership: I (Indirect) Footnotes: [F5] Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027. [Holding #9] Security: Stock Option (Right to Buy) Ownership: I (Indirect) Footnotes: [F6] Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. [Holding #10] Security: Stock Option (Right to Buy) Ownership: I (Indirect) Footnotes: [F7] Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029. [Holding #11] Security: Restricted Stock Units Ownership: I (Indirect) Footnotes: [F8] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F9] 118 restricted stock units vest on 8/15/2026. [F8] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [Holding #12] Security: Restricted Stock Units Ownership: I (Indirect) Footnotes: [F8] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F10] 160 restricted stock units vest on each of 8/15/2026 and 8/15/2027. [F9] 118 restricted stock units vest on 8/15/2026. [Holding #13] Security: Restricted Stock Units Ownership: I (Indirect) Footnotes: [F8] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F11] 38 restricted stock units vest on 2/3/2027 and 39 restricted stock units vest on 2/3/2028. [F10] 160 restricted stock units vest on each of 8/15/2026 and 8/15/2027. [Holding #14] Security: Restricted Stock Units Ownership: I (Indirect) Footnotes: [F8] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. [F12] 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028. [F11] 38 restricted stock units vest on 2/3/2027 and 39 restricted stock units vest on 2/3/2028. [Holding #15] Security: Stock Option (Right to Buy) Ownership: I (Indirect) Footnotes: [F13] Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028. --- Footnotes (Complete Index) --- F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.091 to $59.1390, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F10: 160 restricted stock units vest on each of 8/15/2026 and 8/15/2027. F11: 38 restricted stock units vest on 2/3/2027 and 39 restricted stock units vest on 2/3/2028. F12: 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028. F13: Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028. F2: This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders. F3: Fully vested. F4: Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026. F5: Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027. F6: Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. F7: Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029. F8: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F9: 118 restricted stock units vest on 8/15/2026. --- Signature --- /s/ /s/ Andrew Nick as Attorney-in-Fact for Amy E. Herr pursuant to Power of Attorney previously filed (2026-02-19)